Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals
ownload free of charge at:
United Therapeutics Corporation Research Report
On December 20, 2013, United Therapeutics Corporation (United Therapeutics) announced that its Orenitram (treprostinil) Extended-Release Tablets have been approved by the United States Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH) in WHO Group I patients to improve exercise capacity. Commenting on the approval, Roger Jeffs, Ph.D., President and Chief Operating Officer of United Therapeutics stated, "This approval marks the first time that the FDA has approved an orally administered prostacyclin analogue for any disease - and our fifth approval from the FDA for treatment of PAH - supporting our mission of providing a wider choice of PAH therapies for physicians and patients. We are grateful for the FDA's thorough review and will continue to build clinical support for the use of Orenitram." The Full Research Report on United Therapeutics Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Perrigo Co. Research Report
On December 18, 2013, Perrigo Co. (Perrigo) announced that the Company has appointed Board of Directors, effective until its annual general meeting on November 2014. The Company informed that Joseph C. Papa, President and CEO of the Company, has been named Chairman of the Board, and Gary K. Kunkle, Jr., has been named Lead Independent Director. Perrigo added that Mr. Papa will head an 11-member Board that will include all of the former membePage: 1 2 3 4 5 Related biology technology :1
. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline2
. California Biomedical Companies Report Higher Product Approvals, Fewer Delays3
. The 2013 CES: Patents, Legislation Reform, and the Growing Market for Patent Attorneys and Agents Reviewed by Wysebridge4
. Synthetic Biologics Announces Proposed Public Offering of Common Stock5
. MiMedx Group Announces Proposed Public Offering of Common Stock6
. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC7
. Northwest Biotherapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants8
. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants9
. DURECT Announces Pricing of Public Offering of Common Stock10
. InterMune Announces Pricing of Public Offering of 6,500,000 Shares of Common Stock11
. Discovery Labs Prices $50 Million Public Offering of Common Stock
(Date:7/29/2014)... Aromas, California (PRWEB) July 29, 2014 ... Droidles is a next generation approach to robotics. What ... toys is patent pending technology that allows them to ... programs, all wirelessly over the internet. , “The invention ... "We're giving the little Droidles a life of their ...
(Date:7/29/2014)... July 29, 2014 White papers ... and cloud based eClinical technologies, have been published by ... These follow a long line of white papers by ... including Life Science Leader, Pharmaceutical Online, and OpenHealthNews. , ... a paper by CTO Marc Desgrousilliers, 'The Five ...
(Date:7/28/2014)... DIEGO , July 28, 2014 ... cultivation technologies, today announced the appointment of biotechnology veteran ... of the board of directors. Levine replaces Cynthia ,CJ, ... immediately. She will remain chairman of the company,s board ... on Sapphire Energy,s mission to deliver commercial scale algae-based ...
(Date:7/28/2014)... 28, 2014 Proove Biosciences , ... be exhibiting data and research conducted through their latest ... Intervention Society’s (ISIS) 22nd Annual Scientific Meeting. The ... Hyatt Regency, in Orlando, Florida. , The ... competence of physicians who care for patients suffering specificity ... Breaking Biology Technology:Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 3Sapphire Energy Announces New CEO James Levine 2Sapphire Energy Announces New CEO James Levine 3Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2
... Texas, May 31, 2011 Lexicon Pharmaceuticals, Inc. ... focused on discovering breakthrough treatments for human disease, announced ... Lexicon,s president and chief executive officer, will present at ... 8, 2011 at 10:30 a.m. Eastern Time in New ...
... 31, 2011 DIME announces ... browser that is designed to deliver targeted, relevant content ... steadily on the rise among physicians. Currently over 86 ... drug information online, according to a recent study. DIME,s ...
... Reportlinker.com announces that a new market ... Global Cell/Tissue Culture Supplies ... This report analyzes the ... US$ Million by the following Product Segments: ...Cached Biology Technology:Lexicon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference 2Physicians' Growing Demand for Point-of-Care Resources Spawns iPointOfCare From Top Continuing Medical Education Provider; DIME 2Global Cell/Tissue Culture Supplies Industry 2Global Cell/Tissue Culture Supplies Industry 3Global Cell/Tissue Culture Supplies Industry 4Global Cell/Tissue Culture Supplies Industry 5Global Cell/Tissue Culture Supplies Industry 6Global Cell/Tissue Culture Supplies Industry 7Global Cell/Tissue Culture Supplies Industry 8Global Cell/Tissue Culture Supplies Industry 9Global Cell/Tissue Culture Supplies Industry 10Global Cell/Tissue Culture Supplies Industry 11Global Cell/Tissue Culture Supplies Industry 12Global Cell/Tissue Culture Supplies Industry 13Global Cell/Tissue Culture Supplies Industry 14Global Cell/Tissue Culture Supplies Industry 15Global Cell/Tissue Culture Supplies Industry 16Global Cell/Tissue Culture Supplies Industry 17Global Cell/Tissue Culture Supplies Industry 18Global Cell/Tissue Culture Supplies Industry 19
(Date:7/28/2014)... professor John Essigmann and colleagues from the University of Washington ... if they could induce the virus to mutate uncontrollably, they ... a strategy that our immune system uses against many viruses. ... HIV to mutate at an enhanced rate, as expected. But ... small clinical trial reported in 2011. In a new study, ...
(Date:7/28/2014)... other forms of dementia, but the research community is ... Washington bioengineers have a designed a peptide structure that ... proteins into a state that,s linked to widespread diseases ... and Lou Gehrig,s disease. The synthetic molecule blocks these ... an abnormally folded form by targeting a toxic intermediate ...
(Date:7/28/2014)... 28, 2014) Rice University researchers are using magnetic ... flexibility that can be used as microscale models for ... "bead-spring" polymers, introduced as theory in the 1950s, can ... and should be of interest to materials scientists who ... led by Rice chemical and biomolecular engineer Sibani Lisa ... Breaking Biology News(10 mins):Forced mutations doom HIV 2Forced mutations doom HIV 3Forced mutations doom HIV 4New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Seeing is bead-lieving 2
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
... I from E. coli is ... enzyme also contains both 5'--3'and ... exonuclease activity enables the enzyme ... in the DNA as starting ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....Biology Products: